Cardiovascular & Haematological Disorders - Drug Targets

463 papers and 5.9k indexed citations i.

About

The 463 papers published in Cardiovascular & Haematological Disorders - Drug Targets in the last decades have received a total of 5.9k indexed citations. Papers published in Cardiovascular & Haematological Disorders - Drug Targets usually cover Cardiology and Cardiovascular Medicine (119 papers), Molecular Biology (79 papers) and Surgery (66 papers) specifically the topics of Natural Antidiabetic Agents Studies (24 papers), Venous Thromboembolism Diagnosis and Management (24 papers) and Antiplatelet Therapy and Cardiovascular Diseases (22 papers). The most active scholars publishing in Cardiovascular & Haematological Disorders - Drug Targets are E. Carlos Rodríguez‐Merchán, Saeed Samarghandian, George L. Tipoe, Tungming Leung, Man‐Lung Fung, David P. Basile, Mervin C. Yöder, Ota Fuchs, Archibald McNicol and Sara J. Israels.

In The Last Decade

Fields of papers published in Cardiovascular & Haematological Disorders - Drug Targets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Cardiovascular & Haematological Disorders - Drug Targets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Cardiovascular & Haematological Disorders - Drug Targets.

Countries where authors publish in Cardiovascular & Haematological Disorders - Drug Targets

Since Specialization
Citations

This map shows the geographic impact of research published in Cardiovascular & Haematological Disorders - Drug Targets. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Cardiovascular & Haematological Disorders - Drug Targets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cardiovascular & Haematological Disorders - Drug Targets more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025